Company that develops and invests in drugs and technologies which prolong human lifespan.
Rejuveron is an integrated biotechnology platform company that develops and improves therapies and technologies to promote healthy aging and prolong lifespan.
We are a dynamic team of experienced drug discovery and development experts, building a new Incubator lab space at the Bio-Technopark in Schlieren (Zurich).
We provide start-up coaching and funding to entrepreneurial scientists to co-create therapies that benefit our aging population.
Visit website: https://rejuveron.com/en/
People at Rejuveron
Rejuveron raises $20 million for Endogena to advance treatment for eye diseases
CISION PR Newswire - 31-Dec-2021
Funds to develop regenerative therapies for retinitis pigmentosa and advanced age-related macular degenerationRead more...
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting yearRead more...